Sigma receptor agonists provide neuroprotection in vitro by preserving bcl-2

Medicine & Life Sciences

• sigma Receptors 100%
• rimcazole 70%
• Neuroprotection 69%
• Oxygen 47%
• Glucose 41%
• In Vitro Techniques 29%
• 4-phenyl-1-(4-phenylbutyl)piperidine 20%
• In Situ Nick-End Labeling 20%
• Glutamic Acid 16%
• DNA Damage 16%
• calcein AM 14%
• Cell Death 14%
• Neurons 11%
• Propidium 10%
• Brain Ischemia 9%
• Brain Injuries 9%
• Reverse Transcription 8%
• Proteins 6%
• Western Blotting 6%
• Staining and Labeling 6%
• Polymerase Chain Reaction 5%
• Messenger RNA 5%
• Wounds and Injuries 4%
• Genes 3%